<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-05T10:51:24Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2117/428202" metadataPrefix="rdf">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2117/428202</identifier><datestamp>2025-07-16T22:24:27Z</datestamp><setSpec>com_2072_1033</setSpec><setSpec>col_2072_452949</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:recercat.cat:2117/428202">
      <dc:title>Analysing metabolic changes in a gastric adenocarcinoma cell line under different drug treatments: a constraint-based modeling approach</dc:title>
      <dc:creator>Benedicto Molina, Xavier</dc:creator>
      <dc:creator>Ponce De Leon, Miguel</dc:creator>
      <dc:subject>Àrees temàtiques de la UPC::Informàtica::Arquitectura de computadors</dc:subject>
      <dc:subject>High performance computing</dc:subject>
      <dc:subject>gastric carcinoma</dc:subject>
      <dc:subject>drug synergies</dc:subject>
      <dc:subject>AGS</dc:subject>
      <dc:subject>metabolic tasks</dc:subject>
      <dc:subject>genome-scale metabolic models</dc:subject>
      <dc:subject>Càlcul intensiu (Informàtica)</dc:subject>
      <dc:description>Gastric carcinoma (GC) is one of the leading causes&#xd;
of cancer death globally. Managing advanced stages of GC&#xd;
necessitates a multifaceted approach, encompassing surgical&#xd;
interventions and comprehensive multidisciplinary strategies&#xd;
such as combinatorial drug treatments, recently emerging as&#xd;
promising avenues. Recent advances in computational biology&#xd;
have facilitated the development of genome-scale metabolic&#xd;
models (GEMs), which offer a comprehensive, mathematical&#xd;
framework for understanding the intricate metabolic dynamics.&#xd;
Integrating these GEMs with high-throughput omics&#xd;
data, GEMs provide a representations of cellular metabolism&#xd;
through metabolic tasks, allowing for the elucidation of complex&#xd;
metabolic phenotypes associated with the effects of combinatorial&#xd;
treatments. Herein, an approach to take advantage of&#xd;
metabolic tasks and high-throughput omics data using the previously&#xd;
described Tasks Inferred from Differential Expression&#xd;
(TIDEs) approach in conjunction with vital genes to metabolic&#xd;
tasks (anchor genes) is presented as ag-TIDEs.&#xd;
The aim of this work is to explore aberrant metabolic&#xd;
phenotypes using different approaches to generate hypotheses&#xd;
on the mechanisms underlying the observed synergies in the&#xd;
combinatorial drug treatments of TAK1, MEK, and PI3K&#xd;
inhibitors on cells from the AGS cell line. Preliminary results&#xd;
propose distinct metabolic alterations induced by the drug&#xd;
treatments as a hypothesis to be further explored.</dc:description>
      <dc:date>2023-05</dc:date>
      <dc:type>Conference report</dc:type>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>Open Access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
      <dc:publisher>Barcelona Supercomputing Center</dc:publisher>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>